Loring Wolcott & Coolidge Fiduciary Advisors’s Hologic HOLX Stock Holding History

Loring Wolcott & Coolidge Fiduciary Advisors’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-600	Closed	-$46K	–	652
2022 Q1	$46K	Hold	600	–	–	﹤0.01%	451
2021 Q4	$46K	Hold	600	–	–	﹤0.01%	469
2021 Q3	$44K	Sell	600 -33	-5%	-$2.48K	﹤0.01%	469
2021 Q2	$42K	Buy	+633	New	+$42.3K	﹤0.01%	485
2021 Q1	–	Sell	-33	Closed	-$2K	–	482
2020 Q4	$2K	Hold	33	–	–	﹤0.01%	746
2020 Q3	$2K	Hold	33	–	–	﹤0.01%	569
2020 Q2	$2K	Hold	33	–	–	﹤0.01%	563
2020 Q1	$1K	Hold	33	–	–	﹤0.01%	633
2019 Q4	$2K	Hold	33	–	–	﹤0.01%	647
2019 Q3	$2K	Sell	33 -55	-63%	-$2.71K	﹤0.01%	642
2019 Q2	$4K	Hold	88	–	–	﹤0.01%	624
2019 Q1	$4K	Buy	88 +55	+167%	+$2.48K	﹤0.01%	603
2018 Q4	$1K	Hold	33	–	–	﹤0.01%	671
2018 Q3	$1K	Hold	33	–	–	﹤0.01%	631
2018 Q2	$1K	Hold	33	–	–	﹤0.01%	645
2018 Q1	$1K	Hold	33	–	–	﹤0.01%	695
2017 Q4	$1K	Hold	33	–	–	﹤0.01%	693
2017 Q3	$1K	Buy	+33	New	+$1.33K	﹤0.01%	713
2014 Q1	–	Sell	-94	Closed	-$2K	–	628
2013 Q4	$2K	Buy	+94	New	+$2.07K	﹤0.01%	584

Other funds holding HOLX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Loring Wolcott & Coolidge Fiduciary Advisors's HOLX Position: Q2 2022 in Review

Loring Wolcott & Coolidge Fiduciary Advisors sold out of Hologic (HOLX) in Q2 2022, closing a stake of 600 shares — an estimated $46K sold.

Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in HOLX in Q4 2013 and held it in 19 quarters. The position peaked at $46K in Q1 2022. 695 funds tracked by Wall St. Rank hold HOLX as of Q2 2022.

Loring Wolcott & Coolidge Fiduciary Advisors reported no remaining Hologic position as of Q2 2022 after selling out during the quarter.
Loring Wolcott & Coolidge Fiduciary Advisors sold 600 Hologic shares in Q2 2022, an estimated $46K.
Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in Hologic in Q4 2013 and held it in 19 quarters.
Loring Wolcott & Coolidge Fiduciary Advisors's Hologic position peaked at $46K in Q1 2022.
695 funds tracked by Wall St. Rank held Hologic as of Q2 2022.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q2 2022, filed 26 Jul 2022.